In the BioHarmony Drug Report Database
Darbepoetin alfa
Aranesp (darbepoetin alfa) is a protein pharmaceutical. Darbepoetin alfa was first approved as Aranesp on 2001-06-08. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
Trade Name
|
Aranesp |
|---|---|
Common Name
|
darbepoetin alfa |
ChEMBL ID
|
CHEMBL1201566 |
Indication
|
anemia, chronic kidney failure, neoplasms |
Drug Class
|
Erythropoietins |
Image (chem structure or protein)
